BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection-Reference-Cited by-同舟云学术

BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection

Published:2021-07-19 Issue:8 Volume:22 Page:996-1007
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Chen Yao,Zander Ryan A.,Wu Xiaopeng,Schauder David M.,Kasmani Moujtaba Y.^ORCID,Shen Jian^ORCID,Zheng Shikan,Burns Robert,Taparowsky Elizabeth J.^ORCID,Cui Weiguo^ORCID

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

American Cancer Society

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-021-00965-7.pdf

Reference65 articles.

1. Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).

2. He, R. et al. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection. Nature 537, 412–428 (2016).

3. Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417–421 (2016).

4. Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415–427 (2016).

5. Leong, Y. A. et al. CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles. Nat. Immunol. 17, 1187–1196 (2016).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

2. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

3. T cell exhaustion and senescence for ovarian cancer immunotherapy;Seminars in Cancer Biology;2024-09

4. New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them;Trends in Biochemical Sciences;2024-09

5. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09